JAKARTA - As many as 248 volunteers have undergone vaccine injections in the context of clinical trials of the vaccine from China. This was conveyed by the Clinical Trial Research Team for the COVID-19 Sinovac Vaccine from Padjadjaran University (Unpad).
The Manager of the Sinovac COVID-19 Vaccine Clinical Trial Research Team, Eddy Fadliyana, said of the 248 volunteers who had undergone the injection, 21 of them had already undergone the second injection of the vaccine.
"As many as 21 people have been injected twice and there are no serious symptoms," said Eddy in Bandung, as reported by Antara, Sunday, August 30.
With the ongoing vaccine trial process, he hopes the research can be in line with expectations because new vaccines can be produced when clinical trials have been carried out with good results.
So far, according to him, none of the volunteers have experienced symptoms or serious reactions after undergoing the vaccine injection, either the first injection or the second injection.
Previously, West Java Governor Ridwan Kamil along with other regional officials also volunteered for the vaccine clinical trial.
Ridwan Kamil admitted that he experienced a bit of aches in his body after undergoing the vaccine injection.
"So after the injection, my personal testimony is a bit sore, there is a sense of burning for five minutes," said Ridwan Kamil.
Ridwan Kamil is a volunteer among 1,620 volunteers who will undergo vaccine injections. These thousands of volunteers are needed to become the subjects of the clinical trial of the Sinovac COVID-19 vaccine, which is planned for mass production in 2021.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)